Machine learning-based prediction model for hypofibrinogenemia after tigecycline therapy
{{output}}
Background: In clinical practice, the incidence of hypofibrinogenemia (HF) after tigecycline (TGC) treatment significantly exceeds the probability claimed by drug manufacturers. ... ...
